Duncan Bucknell

Strategic Intellectual Property

Menu
  • Our Services
  • Insights & News
  • How we help you succeed
  • About us

Duncan Bucknell

Strategic Intellectual Property

Duncan

Posts by Duncan:
  • Clash of brands without trade marks
  • Tangling in your pre-litigation strategy
  • IP update: vaccines, counterfeits, textbook piracy and tm translations
  • Strategic litigation, costs assessments, security for costs and trade mark use
  • AI & IP – a brief update
  • Apple wallet may have a widget, virtual concerts, landmark UPC decision, India UK FTA and semi nude photos
  • Be prepared before you engage: Zest Labs, Walmat and $222m in damages
  • A ground of invalidity is not the prior art itself, IOENGINE’s flash drive patents gone and no Estoppel
  • US Copyright AI report & Director Fired, House of Lords AI amendment and US Estoppel aint what it used to be
  • ‘Defining the invention’ is not ‘sufficiency’, careful how you argue a ‘chilling effect’ and ‘fair basis’ is not ‘support’ – Amgen’s Repatha claims upheld in Federal Court appeal
« 1 … 6 7 8 9 10 … 152 »
Duncan Bucknell
duncan@duncanbucknell.com
+61 427 003 423

Insights & News

  • Commercial IP, deals and contracts
  • Disputes and Litigation
  • IP Rights
    • Brands and Trade Marks
    • Copyright and Designs
    • Inventions & Patents
    • Trade Secrets
  • Strategic Advice
    • Coaching
    • Develop IP
    • Enforce and defend your IP
    • Increase IP Value
    • Inform and improve your IP Strategy
    • IP Management
    • Product Strategy
    • Pursue Excellence
    • Risk management

Liability limited by a scheme approved under Professional Standards Legislation

Duncan Bucknell

Loading Comments...

You must be logged in to post a comment.